HEADER HYDROLASE/HYDROLASE INHIBITOR 10-JUL-14 4QUL TITLE CASPASE-3 F55W COMPND MOL_ID: 1; COMPND 2 MOLECULE: CASPASE-3; COMPND 3 CHAIN: A, C; COMPND 4 SYNONYM: CASP-3, APOPAIN, CYSTEINE PROTEASE CPP32, CPP-32, PROTEIN COMPND 5 YAMA, SREBP CLEAVAGE ACTIVITY 1, SCA-1, CASPASE-3 SUBUNIT P17, COMPND 6 CASPASE-3 SUBUNIT P12; COMPND 7 EC: 3.4.22.56; COMPND 8 ENGINEERED: YES; COMPND 9 MUTATION: YES; COMPND 10 MOL_ID: 2; COMPND 11 MOLECULE: ACE-ASP-GLU-VAL-ASP-CHLOROMETHYLKETONE INHIBITOR; COMPND 12 CHAIN: G, F; COMPND 13 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CASP3, CPP32; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 MOL_ID: 2; SOURCE 9 SYNTHETIC: YES KEYWDS ALLOSTERIC NETWORK, HYDROLASE-HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR C.CADE,P.D.SWARTZ,S.H.MACKENZIE,A.C.CLARK REVDAT 4 06-NOV-24 4QUL 1 REMARK SEQADV LINK REVDAT 3 22-NOV-17 4QUL 1 REMARK REVDAT 2 24-DEC-14 4QUL 1 JRNL REVDAT 1 05-NOV-14 4QUL 0 JRNL AUTH C.CADE,P.SWARTZ,S.H.MACKENZIE,A.C.CLARK JRNL TITL MODIFYING CASPASE-3 ACTIVITY BY ALTERING ALLOSTERIC JRNL TITL 2 NETWORKS. JRNL REF BIOCHEMISTRY V. 53 7582 2014 JRNL REFN ISSN 0006-2960 JRNL PMID 25343534 JRNL DOI 10.1021/BI500874K REMARK 2 REMARK 2 RESOLUTION. 1.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE: 1.9_1692) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 33.77 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.2 REMARK 3 NUMBER OF REFLECTIONS : 43961 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.217 REMARK 3 R VALUE (WORKING SET) : 0.215 REMARK 3 FREE R VALUE : 0.258 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.560 REMARK 3 FREE R VALUE TEST SET COUNT : 2005 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 33.7783 - 4.5709 0.98 3045 146 0.1735 0.1908 REMARK 3 2 4.5709 - 3.6294 0.97 2991 144 0.1582 0.2055 REMARK 3 3 3.6294 - 3.1710 0.98 3020 145 0.1849 0.2216 REMARK 3 4 3.1710 - 2.8812 0.99 3046 149 0.2074 0.2479 REMARK 3 5 2.8812 - 2.6748 0.99 3034 137 0.2220 0.2524 REMARK 3 6 2.6748 - 2.5172 0.99 3025 148 0.2234 0.2868 REMARK 3 7 2.5172 - 2.3911 1.00 3021 145 0.2365 0.2686 REMARK 3 8 2.3911 - 2.2871 0.99 3041 140 0.2279 0.2762 REMARK 3 9 2.2871 - 2.1991 0.96 2910 137 0.2827 0.4075 REMARK 3 10 2.1991 - 2.1232 0.99 3004 148 0.2421 0.2779 REMARK 3 11 2.1232 - 2.0568 0.98 3027 140 0.2679 0.3323 REMARK 3 12 2.0568 - 1.9980 1.00 3027 151 0.2579 0.3120 REMARK 3 13 1.9980 - 1.9454 0.99 3001 149 0.2838 0.3300 REMARK 3 14 1.9454 - 1.8980 0.91 2764 126 0.4165 0.4167 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.270 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 29.420 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.008 3949 REMARK 3 ANGLE : 1.150 5308 REMARK 3 CHIRALITY : 0.050 570 REMARK 3 PLANARITY : 0.005 677 REMARK 3 DIHEDRAL : 14.270 1465 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4QUL COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 14-JUL-14. REMARK 100 THE DEPOSITION ID IS D_1000086532. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 19-JUN-13 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 22-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : CRYSTAL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 300 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 43961 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.898 REMARK 200 RESOLUTION RANGE LOW (A) : 33.773 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.2 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.09 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.14 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.6 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 44.79 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.23 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PROTEINS WERE DIALYZED IN A BUFFER OF REMARK 280 10 MM TRIS-HCL, PH 8.5, 1 MM DTT AND CONCENTRATED TO 10 MG/ML. REMARK 280 INHIBITOR, AC-DEVD-CMK RECONSTITUTED IN DMSO, WAS THEN ADDED AT REMARK 280 A 5:1 INHIBITOR:PEPTIDE RATIO (W/W). THE PROTEIN WAS DILUTED TO REMARK 280 A CONCENTRATION OF 8 MG/ML BY ADDING 10 MM TRIS-HCL, PH 8.5, REMARK 280 CONCENTRATED DTT, AND CONCENTRATED NAN3 SO THAT THE FINAL BUFFER REMARK 280 CONSISTED OF 10 MM TRIS-HCL, PH 8.5, 10 MM DTT, AND 3 MM NAN3. REMARK 280 CRYSTALS WERE OBTAINED AT 291K BY THE HANGING DROP VAPOR REMARK 280 DIFFUSION METHOD USING 4 UL DROPS THAT CONTAINED EQUAL VOLUMES REMARK 280 OF PROTEIN AND RESERVOIR SOLUTIONS OVER A 0.5 ML RESERVOIR. THE REMARK 280 RESERVOIR SOLUTIONS FOR OPTIMAL CRYSTAL GROWTH CONSISTED OF 100 REMARK 280 MM SODIUM CITRATE, PH 5.0, 3 MM NAN3, 10 MM DTT, AND 10% 16% PEG REMARK 280 6000 (W/V). CRYSTALS APPEARED WITHIN 3.5 TO 6 WEEKS FOR ALL REMARK 280 MUTANTS, VAPOR DIFFUSION, HANGING DROP REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 54.25400 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 48.37600 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 54.25400 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 48.37600 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 6960 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 18280 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -10.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C, G, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 REMARK 400 THE AC-ASP-GLU-VAL-ASP-CMK IS PEPTIDE-LIKE, A MEMBER OF INHIBITOR REMARK 400 CLASS. REMARK 400 REMARK 400 GROUP: 1 REMARK 400 NAME: AC-ASP-GLU-VAL-ASP-CMK REMARK 400 CHAIN: G, F REMARK 400 COMPONENT_1: PEPTIDE LIKE POLYMER REMARK 400 DESCRIPTION: NULL REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 GLU A 2 REMARK 465 ASN A 3 REMARK 465 THR A 4 REMARK 465 GLU A 5 REMARK 465 ASN A 6 REMARK 465 SER A 7 REMARK 465 VAL A 8 REMARK 465 ASP A 9 REMARK 465 SER A 10 REMARK 465 LYS A 11 REMARK 465 SER A 12 REMARK 465 ILE A 13 REMARK 465 LYS A 14 REMARK 465 ASN A 15 REMARK 465 LEU A 16 REMARK 465 GLU A 17 REMARK 465 PRO A 18 REMARK 465 LYS A 19 REMARK 465 ILE A 20 REMARK 465 ILE A 21 REMARK 465 HIS A 22 REMARK 465 GLY A 23 REMARK 465 SER A 24 REMARK 465 GLU A 25 REMARK 465 SER A 26 REMARK 465 MET A 27 REMARK 465 ASP A 28 REMARK 465 SER A 29 REMARK 465 GLY A 30 REMARK 465 ILE A 31 REMARK 465 SER A 32 REMARK 465 LEU A 33 REMARK 465 HIS A 56 REMARK 465 LYS A 57 REMARK 465 SER A 58 REMARK 465 THR A 174 REMARK 465 ASP A 175 REMARK 465 SER A 176 REMARK 465 GLY A 177 REMARK 465 VAL A 178 REMARK 465 ASP A 179 REMARK 465 ASP A 180 REMARK 465 ASP A 181 REMARK 465 MET A 182 REMARK 465 ALA A 183 REMARK 465 CYS A 184 REMARK 465 LEU A 278 REMARK 465 MET C 1 REMARK 465 GLU C 2 REMARK 465 ASN C 3 REMARK 465 THR C 4 REMARK 465 GLU C 5 REMARK 465 ASN C 6 REMARK 465 SER C 7 REMARK 465 VAL C 8 REMARK 465 ASP C 9 REMARK 465 SER C 10 REMARK 465 LYS C 11 REMARK 465 SER C 12 REMARK 465 ILE C 13 REMARK 465 LYS C 14 REMARK 465 ASN C 15 REMARK 465 LEU C 16 REMARK 465 GLU C 17 REMARK 465 PRO C 18 REMARK 465 LYS C 19 REMARK 465 ILE C 20 REMARK 465 ILE C 21 REMARK 465 HIS C 22 REMARK 465 GLY C 23 REMARK 465 SER C 24 REMARK 465 GLU C 25 REMARK 465 SER C 26 REMARK 465 MET C 27 REMARK 465 ASP C 28 REMARK 465 GLY C 30 REMARK 465 ILE C 31 REMARK 465 SER C 32 REMARK 465 LEU C 33 REMARK 465 THR C 174 REMARK 465 ASP C 175 REMARK 465 SER C 176 REMARK 465 GLY C 177 REMARK 465 VAL C 178 REMARK 465 ASP C 179 REMARK 465 ASP C 180 REMARK 465 ASP C 181 REMARK 465 MET C 182 REMARK 465 ALA C 183 REMARK 465 CYS C 184 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ASP A 34 CG OD1 OD2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OD1 ASP C 34 O HOH C 313 2.16 REMARK 500 O ASP G 5 O HOH G 104 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 120 -177.94 -175.59 REMARK 500 ARG C 64 71.27 -117.82 REMARK 500 ALA C 162 148.80 -172.91 REMARK 500 LYS C 229 -47.52 -130.34 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 HIS C 277 LEU C 278 -148.86 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE AZI A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE AZI A 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE AZI A 303 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN G OF ACE-ASP-GLU-VAL-ASP REMARK 800 -CHLOROMETHYLKETONE INHIBITOR REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN F OF ACE-ASP-GLU-VAL-ASP REMARK 800 -CHLOROMETHYLKETONE INHIBITOR REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4QTX RELATED DB: PDB REMARK 900 RELATED ID: 4QU0 RELATED DB: PDB REMARK 900 RELATED ID: 4QU5 RELATED DB: PDB REMARK 900 RELATED ID: 4QU8 RELATED DB: PDB REMARK 900 RELATED ID: 4QU9 RELATED DB: PDB REMARK 900 RELATED ID: 4QUA RELATED DB: PDB REMARK 900 RELATED ID: 4QUB RELATED DB: PDB REMARK 900 RELATED ID: 4QUD RELATED DB: PDB REMARK 900 RELATED ID: 4QUE RELATED DB: PDB REMARK 900 RELATED ID: 4QUG RELATED DB: PDB REMARK 900 RELATED ID: 4QUH RELATED DB: PDB REMARK 900 RELATED ID: 4QUI RELATED DB: PDB REMARK 900 RELATED ID: 4QUJ RELATED DB: PDB REMARK 900 RELATED ID: 4QUL RELATED DB: PDB DBREF 4QUL A 1 277 UNP P42574 CASP3_HUMAN 1 277 DBREF 4QUL C 1 277 UNP P42574 CASP3_HUMAN 1 277 DBREF 4QUL G 1 6 PDB 4QUL 4QUL 1 6 DBREF 4QUL F 1 6 PDB 4QUL 4QUL 1 6 SEQADV 4QUL TRP A 55 UNP P42574 PHE 55 ENGINEERED MUTATION SEQADV 4QUL LEU A 278 UNP P42574 EXPRESSION TAG SEQADV 4QUL TRP C 55 UNP P42574 PHE 55 ENGINEERED MUTATION SEQADV 4QUL LEU C 278 UNP P42574 EXPRESSION TAG SEQRES 1 A 278 MET GLU ASN THR GLU ASN SER VAL ASP SER LYS SER ILE SEQRES 2 A 278 LYS ASN LEU GLU PRO LYS ILE ILE HIS GLY SER GLU SER SEQRES 3 A 278 MET ASP SER GLY ILE SER LEU ASP ASN SER TYR LYS MET SEQRES 4 A 278 ASP TYR PRO GLU MET GLY LEU CYS ILE ILE ILE ASN ASN SEQRES 5 A 278 LYS ASN TRP HIS LYS SER THR GLY MET THR SER ARG SER SEQRES 6 A 278 GLY THR ASP VAL ASP ALA ALA ASN LEU ARG GLU THR PHE SEQRES 7 A 278 ARG ASN LEU LYS TYR GLU VAL ARG ASN LYS ASN ASP LEU SEQRES 8 A 278 THR ARG GLU GLU ILE VAL GLU LEU MET ARG ASP VAL SER SEQRES 9 A 278 LYS GLU ASP HIS SER LYS ARG SER SER PHE VAL CYS VAL SEQRES 10 A 278 LEU LEU SER HIS GLY GLU GLU GLY ILE ILE PHE GLY THR SEQRES 11 A 278 ASN GLY PRO VAL ASP LEU LYS LYS ILE THR ASN PHE PHE SEQRES 12 A 278 ARG GLY ASP ARG CYS ARG SER LEU THR GLY LYS PRO LYS SEQRES 13 A 278 LEU PHE ILE ILE GLN ALA CYS ARG GLY THR GLU LEU ASP SEQRES 14 A 278 CYS GLY ILE GLU THR ASP SER GLY VAL ASP ASP ASP MET SEQRES 15 A 278 ALA CYS HIS LYS ILE PRO VAL GLU ALA ASP PHE LEU TYR SEQRES 16 A 278 ALA TYR SER THR ALA PRO GLY TYR TYR SER TRP ARG ASN SEQRES 17 A 278 SER LYS ASP GLY SER TRP PHE ILE GLN SER LEU CYS ALA SEQRES 18 A 278 MET LEU LYS GLN TYR ALA ASP LYS LEU GLU PHE MET HIS SEQRES 19 A 278 ILE LEU THR ARG VAL ASN ARG LYS VAL ALA THR GLU PHE SEQRES 20 A 278 GLU SER PHE SER PHE ASP ALA THR PHE HIS ALA LYS LYS SEQRES 21 A 278 GLN ILE PRO CYS ILE VAL SER MET LEU THR LYS GLU LEU SEQRES 22 A 278 TYR PHE TYR HIS LEU SEQRES 1 C 278 MET GLU ASN THR GLU ASN SER VAL ASP SER LYS SER ILE SEQRES 2 C 278 LYS ASN LEU GLU PRO LYS ILE ILE HIS GLY SER GLU SER SEQRES 3 C 278 MET ASP SER GLY ILE SER LEU ASP ASN SER TYR LYS MET SEQRES 4 C 278 ASP TYR PRO GLU MET GLY LEU CYS ILE ILE ILE ASN ASN SEQRES 5 C 278 LYS ASN TRP HIS LYS SER THR GLY MET THR SER ARG SER SEQRES 6 C 278 GLY THR ASP VAL ASP ALA ALA ASN LEU ARG GLU THR PHE SEQRES 7 C 278 ARG ASN LEU LYS TYR GLU VAL ARG ASN LYS ASN ASP LEU SEQRES 8 C 278 THR ARG GLU GLU ILE VAL GLU LEU MET ARG ASP VAL SER SEQRES 9 C 278 LYS GLU ASP HIS SER LYS ARG SER SER PHE VAL CYS VAL SEQRES 10 C 278 LEU LEU SER HIS GLY GLU GLU GLY ILE ILE PHE GLY THR SEQRES 11 C 278 ASN GLY PRO VAL ASP LEU LYS LYS ILE THR ASN PHE PHE SEQRES 12 C 278 ARG GLY ASP ARG CYS ARG SER LEU THR GLY LYS PRO LYS SEQRES 13 C 278 LEU PHE ILE ILE GLN ALA CYS ARG GLY THR GLU LEU ASP SEQRES 14 C 278 CYS GLY ILE GLU THR ASP SER GLY VAL ASP ASP ASP MET SEQRES 15 C 278 ALA CYS HIS LYS ILE PRO VAL GLU ALA ASP PHE LEU TYR SEQRES 16 C 278 ALA TYR SER THR ALA PRO GLY TYR TYR SER TRP ARG ASN SEQRES 17 C 278 SER LYS ASP GLY SER TRP PHE ILE GLN SER LEU CYS ALA SEQRES 18 C 278 MET LEU LYS GLN TYR ALA ASP LYS LEU GLU PHE MET HIS SEQRES 19 C 278 ILE LEU THR ARG VAL ASN ARG LYS VAL ALA THR GLU PHE SEQRES 20 C 278 GLU SER PHE SER PHE ASP ALA THR PHE HIS ALA LYS LYS SEQRES 21 C 278 GLN ILE PRO CYS ILE VAL SER MET LEU THR LYS GLU LEU SEQRES 22 C 278 TYR PHE TYR HIS LEU SEQRES 1 G 6 ACE ASP GLU VAL ASP 0QE SEQRES 1 F 6 ACE ASP GLU VAL ASP 0QE HET ACE G 1 3 HET 0QE G 6 1 HET ACE F 1 3 HET 0QE F 6 1 HET AZI A 301 3 HET AZI A 302 3 HET AZI A 303 3 HETNAM ACE ACETYL GROUP HETNAM 0QE CHLOROMETHANE HETNAM AZI AZIDE ION HETSYN 0QE CHLORO METHYL GROUP FORMUL 3 ACE 2(C2 H4 O) FORMUL 3 0QE 2(C H3 CL) FORMUL 5 AZI 3(N3 1-) FORMUL 8 HOH *207(H2 O) HELIX 1 1 GLY A 66 LEU A 81 1 16 HELIX 2 2 THR A 92 LYS A 105 1 14 HELIX 3 3 LEU A 136 ASN A 141 1 6 HELIX 4 4 PHE A 142 ARG A 144 5 3 HELIX 5 5 CYS A 148 THR A 152 5 5 HELIX 6 6 TRP A 214 ALA A 227 1 14 HELIX 7 7 GLU A 231 PHE A 247 1 17 HELIX 8 8 ASP A 253 HIS A 257 5 5 HELIX 9 9 HIS C 56 GLY C 60 5 5 HELIX 10 10 GLY C 66 LEU C 81 1 16 HELIX 11 11 THR C 92 LYS C 105 1 14 HELIX 12 12 LEU C 136 PHE C 142 1 7 HELIX 13 13 CYS C 148 THR C 152 5 5 HELIX 14 14 TRP C 214 ALA C 227 1 14 HELIX 15 15 GLU C 231 PHE C 247 1 17 HELIX 16 16 ASP C 253 HIS C 257 5 5 SHEET 1 A12 GLU A 84 ASN A 89 0 SHEET 2 A12 GLU A 43 ASN A 51 1 N CYS A 47 O ARG A 86 SHEET 3 A12 ARG A 111 LEU A 119 1 O VAL A 117 N ILE A 48 SHEET 4 A12 LYS A 156 GLN A 161 1 O LEU A 157 N PHE A 114 SHEET 5 A12 PHE A 193 TYR A 197 1 O LEU A 194 N PHE A 158 SHEET 6 A12 CYS A 264 SER A 267 -1 O VAL A 266 N TYR A 195 SHEET 7 A12 CYS C 264 SER C 267 -1 O SER C 267 N ILE A 265 SHEET 8 A12 PHE C 193 TYR C 197 -1 N TYR C 195 O VAL C 266 SHEET 9 A12 LYS C 156 GLN C 161 1 N PHE C 158 O LEU C 194 SHEET 10 A12 ARG C 111 LEU C 119 1 N PHE C 114 O LEU C 157 SHEET 11 A12 GLU C 43 ASN C 51 1 N ILE C 48 O VAL C 117 SHEET 12 A12 GLU C 84 ASN C 89 1 O LYS C 88 N ASN C 51 SHEET 1 B 3 GLY A 122 GLU A 123 0 SHEET 2 B 3 ILE A 126 GLY A 129 -1 O ILE A 126 N GLU A 123 SHEET 3 B 3 GLY A 132 ASP A 135 -1 O VAL A 134 N ILE A 127 SHEET 1 C 3 GLY A 212 SER A 213 0 SHEET 2 C 3 TRP A 206 ASN A 208 -1 N ASN A 208 O GLY A 212 SHEET 3 C 3 GLU F 3 VAL F 4 -1 O GLU F 3 N ARG A 207 SHEET 1 D 3 GLY C 122 GLU C 123 0 SHEET 2 D 3 ILE C 126 GLY C 129 -1 O ILE C 126 N GLU C 123 SHEET 3 D 3 GLY C 132 ASP C 135 -1 O GLY C 132 N GLY C 129 SHEET 1 E 2 GLY C 165 GLU C 167 0 SHEET 2 E 2 GLY C 202 TYR C 203 1 O GLY C 202 N GLU C 167 SHEET 1 F 3 GLY C 212 SER C 213 0 SHEET 2 F 3 TRP C 206 ASN C 208 -1 N ASN C 208 O GLY C 212 SHEET 3 F 3 GLU G 3 VAL G 4 -1 O GLU G 3 N ARG C 207 LINK C ACE G 1 N ASP G 2 1555 1555 1.44 LINK C ASP G 5 C1 0QE G 6 1555 1555 1.50 LINK C ACE F 1 N ASP F 2 1555 1555 1.44 LINK C ASP F 5 C1 0QE F 6 1555 1555 1.51 SITE 1 AC1 6 LYS A 137 THR A 140 ASN A 141 GLU A 190 SITE 2 AC1 6 PHE A 193 TYR A 195 SITE 1 AC2 5 ASN A 208 ASP A 211 GLN A 217 HOH A 465 SITE 2 AC2 5 HOH F 102 SITE 1 AC3 5 LYS A 53 GLY A 66 THR A 67 ASP A 68 SITE 2 AC3 5 VAL A 69 SITE 1 AC4 18 ARG C 64 HIS C 121 GLY C 122 GLN C 161 SITE 2 AC4 18 CYS C 163 TYR C 204 SER C 205 TRP C 206 SITE 3 AC4 18 ARG C 207 ASN C 208 SER C 209 TRP C 214 SITE 4 AC4 18 SER C 249 PHE C 250 HOH C 342 HOH G 104 SITE 5 AC4 18 HOH G 105 HOH G 106 SITE 1 AC5 18 ARG A 64 HIS A 121 GLY A 122 GLN A 161 SITE 2 AC5 18 CYS A 163 TYR A 204 SER A 205 TRP A 206 SITE 3 AC5 18 ARG A 207 ASN A 208 SER A 209 TRP A 214 SITE 4 AC5 18 SER A 249 PHE A 250 HOH A 462 HOH F 101 SITE 5 AC5 18 HOH F 102 HOH F 103 CRYST1 108.508 96.752 68.417 90.00 126.63 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009216 0.000000 0.006853 0.00000 SCALE2 0.000000 0.010336 0.000000 0.00000 SCALE3 0.000000 0.000000 0.018214 0.00000